Literature DB >> 16959906

Vigilance state-dependent attenuation of hypercapnic chemoreflex and exaggerated sleep apnea in orexin knockout mice.

Akira Nakamura1, Wei Zhang, Masashi Yanagisawa, Yasuichiro Fukuda, Tomoyuki Kuwaki.   

Abstract

Exogenous administration of orexin can promote wakefulness and respiration. Here we examined whether intrinsic orexin participates in the control of breathing in a vigilance state-dependent manner. Ventilation was recorded together with electroencephalography and electromyography for 6 h during the daytime in prepro-orexin knockout mice (ORX-KO) and wild-type (WT) littermates. Respiratory parameters were separately determined during quiet wakefulness (QW), slow-wave sleep (SWS), or rapid eye movement (REM) sleep. Basal ventilation was normal in ORX-KO, irrespective of vigilance states. The hypercapnic ventilatory response during QW in ORX-KO (0.19 +/- 0.01 ml.min(-1).g(-1).%CO(2)(-1)) was significantly smaller than that in WT mice (0.38 +/- 0.04 ml.min(-1).g(-1).%CO(2)(-1)), whereas the responses during SWS and REM in ORX-KO were comparable to those in WT mice. Hypoxic responses during wake and sleep periods were not different between the genotypes. Spontaneous but not postsigh sleep apneas were more frequent in ORX-KO than in WT littermates during both SWS and REM sleep. Our findings suggest that orexin plays a crucial role both in CO(2) sensitivity during wakefulness and in preserving ventilation stability during sleep.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16959906     DOI: 10.1152/japplphysiol.00679.2006

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  52 in total

Review 1.  Translational approaches to understanding metabolic dysfunction and cardiovascular consequences of obstructive sleep apnea.

Authors:  Luciano F Drager; Vsevolod Y Polotsky; Christopher P O'Donnell; Sergio L Cravo; Geraldo Lorenzi-Filho; Benedito H Machado
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-07-31       Impact factor: 4.733

2.  Functional link between the hypocretin and serotonin systems in the neural control of breathing and central chemosensitivity.

Authors:  Andrea E Corcoran; George B Richerson; Michael B Harris
Journal:  J Neurophysiol       Date:  2015-04-15       Impact factor: 2.714

Review 3.  State-dependent central chemoreception: a role of orexin.

Authors:  Tomoyuki Kuwaki; Aihua Li; Eugene Nattie
Journal:  Respir Physiol Neurobiol       Date:  2010-02-17       Impact factor: 1.931

Review 4.  The hypocretins/orexins: integrators of multiple physiological functions.

Authors:  Jingcheng Li; Zhian Hu; Luis de Lecea
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

5.  A severely sleep deprived patient.

Authors:  Anastasios Bonakis; Robin S Howard; Christopher Kosky; Adrian Williams
Journal:  J Clin Sleep Med       Date:  2008-08-15       Impact factor: 4.062

Review 6.  Central chemoreception in wakefulness and sleep: evidence for a distributed network and a role for orexin.

Authors:  Eugene Nattie; Aihua Li
Journal:  J Appl Physiol (1985)       Date:  2010-02-04

7.  Activity of Tachykinin1-Expressing Pet1 Raphe Neurons Modulates the Respiratory Chemoreflex.

Authors:  Morgan L Hennessy; Andrea E Corcoran; Rachael D Brust; YoonJeung Chang; Eugene E Nattie; Susan M Dymecki
Journal:  J Neurosci       Date:  2017-01-16       Impact factor: 6.167

Review 8.  Respiration and autonomic regulation and orexin.

Authors:  Eugene Nattie; Aihua Li
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

Review 9.  Hypothalamic orexins/hypocretins as regulators of breathing.

Authors:  Rhîannan H Williams; Denis Burdakov
Journal:  Expert Rev Mol Med       Date:  2008-10-02       Impact factor: 5.600

10.  Antagonism of orexin receptor-1 in the retrotrapezoid nucleus inhibits the ventilatory response to hypercapnia predominantly in wakefulness.

Authors:  Mirela Barros Dias; Aihua Li; Eugene E Nattie
Journal:  J Physiol       Date:  2009-03-09       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.